Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome

Relapse after allogeneic stem cell transplant in unfavorable-risk acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) portends a poor prognosis. We conducted a single-center phase I dose-escalation study with lenalidomide maintenance in high-risk MDS and AML patients after allo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Brian, Hoeg, Rasmus, Krishnan, Rajeev, Richman, Carol, Tuscano, Joseph, Abedi, Mehrdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636264/
https://www.ncbi.nlm.nih.gov/pubmed/34471239
http://dx.doi.org/10.1038/s41409-021-01444-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636264/
https://www.ncbi.nlm.nih.gov/pubmed/34471239
http://dx.doi.org/10.1038/s41409-021-01444-1

Ejemplares similares